Dr. T. Geetha has over 16 years of research and formulation expertise. Her broad formulation experience includes solid oral dose development for NCE, ANDA, 505(b)2, Semisolid doses, and NDDS. Geetha has been published in 15 global research publications, a book, and two patents. She previously held various research and formulation roles at Syngene International Ltd., Genovo Development Services, and Piramal Healthcare Ltd.
.svg)
